IL138160A0 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number: IL138160A0
Authority: IL; Israel
Prior art keywords: quinoline derivatives; quinoline; derivatives
Prior art date: 1998-04-27

Application number

IL13816099A

Other languages

English (en)

Original Assignee

Active Biotech Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-27

Filing date

1999-04-26

Publication date

2001-10-31

1999-04-26 Application filed by Active Biotech Ab filed Critical Active Biotech Ab

2001-10-31 Publication of IL138160A0 publication Critical patent/IL138160A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL13816099A 1998-04-27 1999-04-26 Quinoline derivatives IL138160A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9801474A SE9801474D0 (sv)	1998-04-27	1998-04-27	Quinoline Derivatives
PCT/SE1999/000676 WO1999055678A1 (fr)	1998-04-27	1999-04-26	Derives de quinoline

Publications (1)

Publication Number	Publication Date
IL138160A0 true IL138160A0 (en)	2001-10-31

Family

ID=20411103

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL13816099A IL138160A0 (en)	1998-04-27	1999-04-26	Quinoline derivatives
IL138160A IL138160A (en)	1998-04-27	2000-08-30	Quinoline derivatives

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL138160A IL138160A (en)	1998-04-27	2000-08-30	Quinoline derivatives

Country Status (32)

Country	Link
EP (1)	EP1073639B1 (fr)
JP (1)	JP4045069B2 (fr)
KR (1)	KR100571534B1 (fr)
CN (1)	CN1113057C (fr)
AP (1)	AP1293A (fr)
AT (1)	ATE228505T1 (fr)
AU (1)	AU747550B2 (fr)
BR (1)	BR9909925B1 (fr)
CA (1)	CA2329788C (fr)
CZ (1)	CZ297439B6 (fr)
DE (1)	DE69904162T2 (fr)
DK (1)	DK1073639T3 (fr)
EE (1)	EE04275B1 (fr)
ES (1)	ES2188242T3 (fr)
HR (1)	HRP20000726B1 (fr)
HU (1)	HU227709B1 (fr)
ID (1)	ID26277A (fr)
IL (2)	IL138160A0 (fr)
IS (1)	IS2082B (fr)
ME (1)	ME00870B (fr)
NO (1)	NO315606B1 (fr)
NZ (1)	NZ506641A (fr)
OA (1)	OA11547A (fr)
PL (1)	PL190441B1 (fr)
PT (1)	PT1073639E (fr)
RS (1)	RS50029B (fr)
RU (1)	RU2197481C2 (fr)
SE (1)	SE9801474D0 (fr)
TR (1)	TR200003061T2 (fr)
UA (1)	UA60354C2 (fr)
WO (1)	WO1999055678A1 (fr)
ZA (1)	ZA200004601B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0002320D0 (sv) *	1999-10-25	2000-06-21	Active Biotech Ab	Malignant tumors
SE0201778D0 (sv) *	2002-06-12	2002-06-12	Active Biotech Ab	Process for the manufacture of quinoline derivatives
KR100908655B1 (ko)	2002-11-27	2009-07-21	엘지디스플레이 주식회사	데이터 공급시간의 변조방법과 이를 이용한액정표시장치의 구동방법 및 장치
SE0400235D0 (sv) *	2004-02-06	2004-02-06	Active Biotech Ab	New composition containing quinoline compounds
SE0401578D0 (sv) *	2004-06-18	2004-06-18	Active Biotech Ab	Novel compounds
US7838522B2 (en)	2004-11-17	2010-11-23	Ares Trading S.A.	Benzothiazole formulations and use thereof
RS52193B (sr)	2004-12-21	2012-10-31	Merck Serono Sa.	Ciklični derivati sulfonil amina i njihova upotreba
DK1844032T3 (da)	2005-01-31	2011-10-24	Merck Serono Sa	N-hydroxyamid-derivater og deres anvendelse
BRPI0613042A2 (pt)	2005-07-15	2010-12-14	Serono Lab	inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko)	2005-07-15	2008-05-21	라보라뚜와르 세로노 에스. 에이.	자궁내막증 치료용 ｊｎｋ 억제제
AU2006286489B2 (en)	2005-09-01	2012-08-09	Ares Trading S.A.	Treatment of optic neuritis
SI1937642T1 (sl) *	2005-10-19	2015-01-30	Teva Pharmaceutical Industries Ltd.	Kristali natrijevega lakvinimoda in postopek za njihovo pripravo
CN101466379B (zh) *	2006-06-12	2012-10-31	泰华制药工业有限公司	稳定的拉喹莫德的制剂
EP2234485B1 (fr)	2007-12-20	2013-11-13	Teva Pharmaceutical Industries, Ltd.	Préparations de laquinimod stables
KR20110048571A (ko)	2008-09-03	2011-05-11	테바 파마슈티컬 인더스트리즈 리미티드	면역 기능을 지닌 ２―옥소―１,２―다이하이드로―퀴놀린 조절제
RS54707B1 (sr) *	2009-07-30	2016-08-31	Teva Pharmaceutical Industries Ltd.	Tretman kronove bolesti lakvinimodom
PL2467372T3 (pl) *	2009-08-10	2017-04-28	Teva Pharmaceutical Industries Ltd.	Leczenie zaburzeń związanych z BDNF z zastosowaniem lakwinimodu
US8889661B2 (en) *	2010-03-03	2014-11-18	Teva Pharmaceutical Industries, Ltd.	Treatment of lupus nephritis using laquinimod
PH12012501741A1 (en) *	2010-03-03	2012-11-12	Teva Pharma	Treatment of lupus arthritis using laquinimod
KR20130014523A (ko)	2010-03-03	2013-02-07	테바 파마슈티컬 인더스트리즈 리미티드	라퀴니모드 및 메토트렉세이트의 병용에 의한 류마티스 관절염의 치료
WO2011116091A1 (fr)	2010-03-17	2011-09-22	Novartis Ag	Distributeur
AU2011275720B2 (en) *	2010-07-09	2015-05-14	Active Biotech Ab	Method for manufacturing of quinoline-3-carboxamides
SG186948A1 (en)	2010-07-09	2013-02-28	Teva Pharma	Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
KR20130041193A (ko) *	2010-07-09	2013-04-24	테바 파마슈티컬 인더스트리즈 리미티드	5-클로로-4-하이드록시-1-메틸-2-옥소-n-페닐-1,2-다이하이드로퀴놀린-3-카복스아마이드, 염 및 그의 용도
EP2444086A1 (fr)	2010-10-22	2012-04-25	Almirall, S.A.	Combinaisons comportant des inhibiteurs de DHODH et de COX
US8889627B2 (en)	2011-10-12	2014-11-18	Teva Pharmaceutical Industries, Ltd.	Treatment of multiple sclerosis with combination of laquinimod and fingolimod
US9161935B2 (en) *	2012-02-03	2015-10-20	Teva Pharmaceutical Industries, Ltd.	Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy
EA201491517A1 (ru)	2012-02-16	2015-03-31	Тева Фармасьютикал Индастриз Лтд.	N-этил-n-фенил-1,2-дигидро-4,5-дигидрокси-1-метил-2-оксо-3-хинолинкарбоксамид, его получение и применения
TW201350467A (zh)	2012-05-08	2013-12-16	Teva Pharma	Ｎ－乙基－４－羥基－１－甲基－５－（甲基（２，３，４，５，６－五羥基己基）胺基）－２－側氧－ｎ－苯基－１，２－二氫喹啉－３－甲醯胺
TW201400117A (zh)	2012-06-05	2014-01-01	Teva Pharma	使用拉喹莫德治療眼發炎疾病
TW201410244A (zh)	2012-08-13	2014-03-16	Teva Pharma	用於治療ｇａｂａ媒介之疾病之拉喹莫德（ｌａｑｕｉｎｉｍｏｄ）
CN104955522A (zh)	2012-11-07	2015-09-30	梯瓦制药工业有限公司	拉喹莫德胺盐
RU2545056C2 (ru) *	2012-12-10	2015-03-27	Государственное бюджетное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия" Министерства здавоохранения и социального развития Российской Федерации (ГБОУ ВПО ПГФА Минздравсоцразвития России)	Противовоспалительное и анальгетическое средство на основе изопропиламида 1,2-дигидро-1н-2-оксоцинхониновой кислоты
CA2900503A1 (fr) *	2013-02-15	2014-08-21	Teva Pharmaceutical Industries Ltd.	Traitement de la sclerose en plaques a l'aide de laquinimod
WO2014153145A2 (fr)	2013-03-14	2014-09-25	Teva Pharmaceutical Industries Ltd.	Cristaux de sodium de laquinimod et procédé amélioré pour leur fabrication
WO2015168103A1 (fr)	2014-04-29	2015-11-05	Teva Pharmaceutical Industries Ltd.	Laquinimod pour le traitement de patients atteints de sclérose en plaques récurrente rémittente (sep-rr) chez ayant un degré d'incapacité élevé
WO2016042112A1 (fr)	2014-09-23	2016-03-24	Active Biotech Ab	Quinoléine carboxamides destinées à être utilisées dans le traitement du myélome multiple
ES2663836T3 (es)	2014-11-19	2018-04-17	Active Biotech Ab	Carboxamidas de quinolina para su uso en el tratamiento de leucemia
DK3886858T3 (da) *	2019-12-19	2022-08-22	Active Biotech Ab	Forbindelser til behandling af øjensygdomme forbundet med for megen vaskularisering
WO2021175924A1 (fr)	2020-03-03	2021-09-10	Active Biotech Ab	Tasquinimod ou sel pharmaceutiquement acceptable de celui-ci destiné à être utilisé en polythérapie
CA3179303A1 (fr) *	2020-05-21	2021-11-25	Darren Orton	Inhibiteurs de notch et leurs utilisations
US20230293512A1 (en)	2020-07-23	2023-09-21	Erasmus University Medical Center Rotterdam	S100 proteins as novel therapeutic targets in myeloproliferative neoplasms
JP2024503372A (ja)	2021-01-18	2024-01-25	アクティブバイオテックエイビー	骨髄異形成症候群の処置における使用のためのタスキニモドまたはその薬学的に許容される塩
WO2022248401A1 (fr)	2021-05-25	2022-12-01	Active Biotech Ab	Pluralité de particules de tasquinimod et utilisation de celles-ci
IL309486A (en)	2021-07-02	2024-02-01	Active Biotech Ab	A pharmacy product containing tesquinimod and a method for evaluating the cleanliness of this product
AU2022421214A1 (en) *	2021-12-20	2024-07-04	The Johns Hopkins University	Compounds for treatment of cancer
WO2025083549A1 (fr)	2023-10-16	2025-04-24	Sun Pharma Advanced Research Company Limited	Méthodes et combinaisons d'inhibiteurs de la voie il-23 et de modulateurs de la voie de signalisation s1p pour le traitement de maladies auto-immunes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE52670B1 (en) *	1981-03-03	1988-01-20	Leo Ab	Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
SU1735288A1 (ru) *	1990-03-05	1992-05-23	Харьковский государственный фармацевтический институт	Способ получени N-R-замещенных амидов 4-гидроксихинолон-2 карбоновой -3-кислоты
GB9108547D0 (en) *	1991-04-22	1991-06-05	Fujisawa Pharmaceutical Co	Quinoline derivatives
DE4120646A1 (de) *	1991-06-22	1992-12-24	Bayer Ag	7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
US5428040A (en) *	1993-08-31	1995-06-27	The Du Pont Merck Pharmaceutical Company	Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
SE9400810D0 (sv) *	1994-03-10	1994-03-10	Pharmacia Ab	New use of Quinoline-3-carboxamide compounds

1998
- 1998-04-27 SE SE9801474A patent/SE9801474D0/xx unknown
1999
- 1999-04-26 CA CA002329788A patent/CA2329788C/fr not_active Expired - Fee Related
- 1999-04-26 ME MEP-2000-612A patent/ME00870B/fr unknown
- 1999-04-26 IL IL13816099A patent/IL138160A0/xx active IP Right Grant
- 1999-04-26 TR TR2000/03061T patent/TR200003061T2/xx unknown
- 1999-04-26 CZ CZ20003849A patent/CZ297439B6/cs not_active IP Right Cessation
- 1999-04-26 ES ES99947036T patent/ES2188242T3/es not_active Expired - Lifetime
- 1999-04-26 HR HR20000726A patent/HRP20000726B1/xx not_active IP Right Cessation
- 1999-04-26 BR BRPI9909925-0A patent/BR9909925B1/pt not_active IP Right Cessation
- 1999-04-26 CN CN99805581A patent/CN1113057C/zh not_active Expired - Fee Related
- 1999-04-26 RU RU2000129672/04A patent/RU2197481C2/ru not_active IP Right Cessation
- 1999-04-26 JP JP2000545838A patent/JP4045069B2/ja not_active Expired - Lifetime
- 1999-04-26 WO PCT/SE1999/000676 patent/WO1999055678A1/fr not_active Ceased
- 1999-04-26 OA OA1200000301A patent/OA11547A/en unknown
- 1999-04-26 DE DE69904162T patent/DE69904162T2/de not_active Expired - Lifetime
- 1999-04-26 AU AU43013/99A patent/AU747550B2/en not_active Ceased
- 1999-04-26 PL PL99343420A patent/PL190441B1/pl unknown
- 1999-04-26 ID IDW20002183A patent/ID26277A/id unknown
- 1999-04-26 AP APAP/P/2000/001933A patent/AP1293A/en active
- 1999-04-26 NZ NZ506641A patent/NZ506641A/en not_active IP Right Cessation
- 1999-04-26 EP EP99947036A patent/EP1073639B1/fr not_active Expired - Lifetime
- 1999-04-26 AT AT99947036T patent/ATE228505T1/de active
- 1999-04-26 HU HU0102084A patent/HU227709B1/hu not_active IP Right Cessation
- 1999-04-26 EE EEP200000613A patent/EE04275B1/xx unknown
- 1999-04-26 UA UA2000085078A patent/UA60354C2/uk unknown
- 1999-04-26 DK DK99947036T patent/DK1073639T3/da active
- 1999-04-26 RS YUP-612/00A patent/RS50029B/sr unknown
- 1999-04-26 KR KR1020007011944A patent/KR100571534B1/ko not_active Expired - Fee Related
- 1999-04-26 PT PT99947036T patent/PT1073639E/pt unknown
2000
- 2000-08-30 IL IL138160A patent/IL138160A/en not_active IP Right Cessation
- 2000-08-31 IS IS5615A patent/IS2082B/is unknown
- 2000-09-01 ZA ZA200004601A patent/ZA200004601B/en unknown
- 2000-10-19 NO NO20005254A patent/NO315606B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
PT1073639E (pt)	2003-04-30
DE69904162D1 (de)	2003-01-09
CN1298393A (zh)	2001-06-06
HRP20000726B1 (hr)	2009-04-30
ATE228505T1 (de)	2002-12-15
CN1113057C (zh)	2003-07-02
JP2002513006A (ja)	2002-05-08
AP2000001933A0 (en)	2000-12-31
JP4045069B2 (ja)	2008-02-13
ES2188242T3 (es)	2003-06-16
HK1036618A1 (en)	2002-01-11
BR9909925B1 (pt)	2010-09-21
WO1999055678A1 (fr)	1999-11-04
AU4301399A (en)	1999-11-16
ZA200004601B (en)	2002-02-27
HUP0102084A3 (en)	2002-12-28
TR200003061T2 (tr)	2001-01-22
OA11547A (en)	2004-05-24
RS50029B (sr)	2008-11-28
NO20005254D0 (no)	2000-10-19
AU747550B2 (en)	2002-05-16
CZ297439B6 (cs)	2006-12-13
AP1293A (en)	2004-08-30
EP1073639A1 (fr)	2001-02-07
HU227709B1 (en)	2011-12-28
YU61200A (sh)	2003-07-07
RU2197481C2 (ru)	2003-01-27
IS5615A (is)	2000-08-31
IL138160A (en)	2006-04-10
HRP20000726A2 (en)	2001-04-30
PL343420A1 (en)	2001-08-13
ID26277A (id)	2000-12-14
CA2329788C (fr)	2004-11-23
PL190441B1 (pl)	2005-12-30
UA60354C2 (uk)	2003-10-15
EP1073639B1 (fr)	2002-11-27
NO20005254L (no)	2000-12-27
DK1073639T3 (da)	2003-03-24
IS2082B (is)	2006-02-15
ME00870B (fr)	2008-11-28
CA2329788A1 (fr)	1999-11-04
DE69904162T2 (de)	2003-08-21
EE200000613A (et)	2002-04-15
BR9909925A (pt)	2001-01-09
NZ506641A (en)	2002-03-28
NO315606B1 (no)	2003-09-29
KR100571534B1 (ko)	2006-04-14
EE04275B1 (et)	2004-04-15
HUP0102084A2 (hu)	2001-11-28
CZ20003849A3 (cs)	2001-03-14
SE9801474D0 (sv)	1998-04-27

Publication	Publication Date	Title
IL143782A0 (en)	2002-04-21	Quinoline derivatives
PL343420A1 (en)	2001-08-13	Quinoline derivatives
AP2001002041A0 (en)	2001-03-31	Quinoline derivatives
GB9904103D0 (en)	1999-04-14	Quinoline derivatives
IL140009A0 (en)	2002-02-10	Quinoline derivatives
HRP20010454B1 (en)	2004-06-30	1,2-annelated quinoline derivatives
PL346155A1 (en)	2002-01-28	1h-imidazopyridine derivatives
PL345540A1 (en)	2001-12-17	Thiobenzimidazole derivatives
SG71898A1 (en)	2000-04-18	Benzosulfone derivatives
AP9500745A0 (en)	1995-07-31	Quinoline derivatives
GB9809664D0 (en)	1998-07-01	a-Ketoamide derivatives
ZA977326B (en)	1999-02-15	Tetrahydroquinoline derivatives
EG23802A (en)	2007-08-22	2-Phenylpyran-4-one derivatives
HU0003938D0 (en)	2000-12-28	Quinolin-4-yl derivatives
HU0003861D0 (en)	2000-12-28	Quinolin-4-yl derivatives
GB9827729D0 (en)	1999-02-10	Thieno-indole derivatives
HU9902270D0 (en)	1999-09-28	Acridin derivatives
EG24161A (en)	2008-08-20	Carbostyril derivatives
EP1061912A4 (fr)	2003-01-02	Derives de phenanthrofuran
IL139276A0 (en)	2001-11-25	Cyclohexenondioxthio chromanoyl derivatives
GB9904104D0 (en)	1999-04-14	Quinoline derivatives
GB9904102D0 (en)	1999-04-14	Quinoline derivatives
GB9904105D0 (en)	1999-04-14	Quinoline derivatives
GB9816279D0 (en)	1998-09-23	Arylthiazolidinedione derivatives
SI1051395T1 (sl)	2007-08-31	N-hidroksiformamidni derivati

Legal Events

Date	Code	Title
2006-09-05	FF	Patent granted
2006-10-04	KB	Patent renewed
2009-11-18	KB	Patent renewed